who makes bpc 157 BPC-157 Explained: Benefits, Safety & Oral vs Injectable Options BPC-157 5mg & 10mg Research

History of Semaglutide and Phentermine Semaglutide was developed by Novo Nordisk as a treatment for type 2 diabetes and marketed as Ozempic in 2017, followed by an oral form called Rybelsus in 2019

Systemic Effects Research demonstrates that BPC-157 exhibits both targeted local effects and systemic migration to areas of tissue damage

Recent human topical evidence A 2023 IRB-approved 21-woman topical trial of NEEL gel (a stabilized GHK-Cu topical) reported an average 28% increase in skin collagen density at 3 months, with a top quartile reporting 51%

All she needs from you is a lab request and your home or office becomes an instant draw station

PVG: Study senior author, study design, overview and final approval of the study